###begin article-title 0
###xml 4 31 4 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 4 30 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The Mycobacterium tuberculosis Rv2540c DNA sequence encodes a bifunctional chorismate synthase
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 55 82 55 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 288 304 288 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 557 573 557 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF</italic>
###xml 55 81 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 288 303 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 323 329 <span type="species:ncbi:9606">humans</span>
###xml 557 572 <span type="species:ncbi:1773">M. tuberculosis</span>
The emergence of multi- and extensively-drug resistant Mycobacterium tuberculosis strains has created an urgent need for new agents to treat tuberculosis (TB). The enzymes of shikimate pathway are attractive targets to the development of antitubercular agents because it is essential for M. tuberculosis and is absent from humans. Chorismate synthase (CS) is the seventh enzyme of this route and catalyzes the NADH- and FMN-dependent synthesis of chorismate, a precursor of aromatic amino acids, naphthoquinones, menaquinones, and mycobactins. Although the M. tuberculosis Rv2540c (aroF) sequence has been annotated to encode a chorismate synthase, there has been no report on its correct assignment and functional characterization of its protein product.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF</italic>
###xml 75 91 75 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 408 410 408 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 607 610 607 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 614 616 614 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 623 626 623 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 75 90 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 92 96 <span type="species:ncbi:1773">MtCS</span>
###xml 379 383 <span type="species:ncbi:1773">MtCS</span>
###xml 408 412 <span type="species:ncbi:1773">MtCS</span>
###xml 614 618 <span type="species:ncbi:1773">MtCS</span>
In the present work, we describe DNA amplification of aroF-encoded CS from M. tuberculosis (MtCS), molecular cloning, protein expression, and purification to homogeneity. N-terminal amino acid sequencing, mass spectrometry and gel filtration chromatography were employed to determine identity, subunit molecular weight and oligomeric state in solution of homogeneous recombinant MtCS. The bifunctionality of MtCS was determined by measurements of both chorismate synthase and NADH:FMN oxidoreductase activities. The flavin reductase activity was characterized, showing the existence of a complex between FMNox and MtCS. FMNox and NADH equilibrium binding was measured. Primary deuterium, solvent and multiple kinetic isotope effects are described and suggest distinct steps for hydride and proton transfers, with the former being more rate-limiting.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">proS </italic>
###xml 187 190 187 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 613 615 613 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 706 708 706 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 706 710 <span type="species:ncbi:1773">MtCS</span>
This is the first report showing that a bacterial CS is bifunctional. Primary deuterium kinetic isotope effects show that C4-proS hydrogen is being transferred during the reduction of FMNox by NADH and that hydride transfer contributes significantly to the rate-limiting step of FMN reduction reaction. Solvent kinetic isotope effects and proton inventory results indicate that proton transfer from solvent partially limits the rate of FMN reduction and that a single proton transfer gives rise to the observed solvent isotope effect. Multiple isotope effects suggest a stepwise mechanism for the reduction of FMNox. The results on enzyme kinetics described here provide evidence for the mode of action of MtCS and should thus pave the way for the rational design of antitubercular agents.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 78 104 78 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 511 526 511 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1126 1130 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">para</italic>
###xml 1153 1154 1153 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 78 104 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 219 225 <span type="species:ncbi:9606">people</span>
###xml 511 526 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 909 916 <span type="species:ncbi:9606">persons</span>
###xml 1217 1222 <span type="species:ncbi:54556">bleak</span>
###xml 1417 1424 <span type="species:ncbi:9606">patient</span>
Tuberculosis (TB) remains a major global health concern. Its causative agent, Mycobacterium tuberculosis, has been estimated to infect approximately one-third of the world's population [1], and approximately 30 million people have died from the disease in the past decade [2]. The World Health Organization estimated a total of 9 million new cases of TB and approximately 2 million deaths from this disease in 2004, second only to AIDS among infectious diseases [3]. The emergence of drug resistant isolates of M. tuberculosis, particularly of multi drug-resistant TB (MDR-TB), defined as resistant to at least isoniazid and rifampicin [4], imposes a great challenge to public health [5]. Treatment of MDR-TB requires the administration of second-line drugs that are more toxic and less effective [6]. More recently, it was reported cases of extensively drug-resistant (XDR) TB, which are defined as cases in persons with TB whose isolates were resistant to isoniazid and rifampicin and at least three of the six main classes of second-line drugs (aminoglycosides, polypeptides, fluoroquinolones, thioamides, cycloserine, and para-aminosalicylic acid) [7]. XDR-TB has a wide geographic distribution and it raises the bleak prospect of a future epidemic of virtually untreatable TB. New antimycobacterial agents are thus needed to improve the treatment of MDR- and XDR-TB, to shorten the treatment course and increase patient compliance, and to provide more effective treatment of latent TB infection.
###end p 9
###begin p 10
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 347 362 347 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 572 576 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroK</italic>
###xml 671 687 671 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 347 362 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 671 686 <span type="species:ncbi:1773">M. tuberculosis</span>
A valuable approach to the development of selective antimicrobial chemotherapy is to exploit the inhibition of targets unique and vital to the pathogen [8]. The enzymes of the shikimate pathway are attractive examples of these targets because this route is essential in higher plants, fungi, bacteria and algae and is absent in mammals [9,10]. In M. tuberculosis, the shikimate pathway leads to the biosynthesis of a wide range of primary and secondary metabolites, including aromatic amino acids, folate, naphthoquinones, menaquinones and mycobactins [11]. Disruption of aroK-encoding shikimate kinase gene has recently shown that the shikimate pathway is essential for M. tuberculosis viability [12], which establishes the enzymes of this pathway as potential targets for the development of new antimycobacterial agents.
###end p 10
###begin p 11
###xml 95 111 95 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 174 175 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF</italic>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">anti</italic>
###xml 390 393 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro</italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 620 623 620 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red</sub>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 712 716 712 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red </sub>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 901 902 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1169 1186 1169 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1454 1458 1454 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF</italic>
###xml 1467 1483 1467 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1504 1506 1504 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1628 1630 1628 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 95 116 <span type="species:ncbi:83332">M. tuberculosis H37Rv</span>
###xml 1169 1185 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1467 1482 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1504 1508 <span type="species:ncbi:1773">MtCS</span>
###xml 1628 1632 <span type="species:ncbi:1773">MtCS</span>
Homologues to the shikimate pathway enzymes were identified in the complete genome sequence of M. tuberculosis H37Rv [13]. Among them, chorismate synthase (CS; EC 4.2.3.5; 5-O-(1-carboxyvinyl)-3-phosphoshikimate phosphate lyase) encoding gene (aroF, Rv2540c) was proposed to be present by sequence homology. CS catalyzes an unusual 1,4-anti-elimination of the 3-phosphate group and the C-(6proR) hydrogen from 5-enolpyruvylshikimate-3-phosphate (EPSP) forming chorismate and phosphate [14]. Although there is no overall change in its redox state, there is an absolute requirement for a reduced flavin mononucleotide (FMNred) [15,16]. Another interesting feature of CSs from different organisms is how reduced FMNred is obtained, which divides these enzymes into two classes: monofunctional and bifunctional [17]. The CSs from fungi are bifunctional as they display a second enzymatic activity (Figure 1), an NAD(P)H-dependent (dependent of reduced form of nicotinamide adenine dinucleotide) flavin reductase (described as "diaphorase" activity in a number of papers), which confers them an intrinsic ability to reduce flavin using NAD(P)H [18]. The CSs from plants and Escherichia coli are monofunctional as they do not possess this activity and are active only in anaerobic conditions in the presence of either chemically or enzymatically reduced flavin [16]. However, there has been no report on both confirmation of the correct assignment of Rv2540c (aroF) as the M. tuberculosis chorismate synthase (MtCS) coding sequence and functional characterization of its protein product. Moreover, there has been no report on whether MtCS is bifunctional or monofunctional.
###end p 11
###begin p 12
Reactions catalysed by bifunctional CSs.
###end p 12
###begin p 13
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF </italic>
###xml 95 110 95 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 151 153 151 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 395 397 395 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 460 476 460 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 650 652 650 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 702 705 702 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 758 760 758 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 873 875 873 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 881 884 881 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 1532 1534 1532 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 95 110 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 151 155 <span type="species:ncbi:1773">MtCS</span>
###xml 395 399 <span type="species:ncbi:1773">MtCS</span>
###xml 460 475 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 650 654 <span type="species:ncbi:1773">MtCS</span>
###xml 758 762 <span type="species:ncbi:1773">MtCS</span>
###xml 873 877 <span type="species:ncbi:1773">MtCS</span>
###xml 1532 1536 <span type="species:ncbi:1773">MtCS</span>
Here we report the amplification and cloning of Rv2540c DNA sequence (putative aroF gene) from M. tuberculosis, and heterologous overexpression of the MtCS protein. The recombinant protein was purified to homogeneity using a three-step purification protocol and its identity was confirmed by N-terminal sequencing, and electrospray ionization mass spectrometry (ESI-MS). The oligomeric state of MtCS was determined by gel filtration. We also show that CS from M. tuberculosis is bifunctional, as in fungi, based on activity measurements of both chorismate synthase and NADH-dependent flavin reductase activities. Moreover, FMN appears to be bound to MtCS based on ionic exchange chromatography, and FMNox (oxidized flavin mononucleotide) and NADH binding to MtCS were assessed by spectroscopic measurements at equilibrium. The apparent kinetic constants for the holoenzyme MtCS-FMNox for NADH were determined. The NADH-dependent flavin reductase activity was characterized by isotope effects. Measurements of primary deuterium and solvent kinetic isotope effects were carried out to probe the nature of the rate-limiting step of the redox reaction. Multiple isotope effects were also determined showing that a stepwise mechanism is involved in this reaction. Proton inventory on the maximal velocity allowed us to address the number of kinetically important transferred protons. The results presented here are important to understand the reaction mechanism of this enzyme, which should pave the way for the rational-based design of MtCS inhibitors with potential antitubercular activity and low toxicity.
###end p 13
###begin title 14
Results and Discussion
###end title 14
###begin title 15
###xml 51 53 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 51 55 <span type="species:ncbi:1773">MtCS</span>
Molecular cloning, expression, and purification of MtCS
###end title 15
###begin p 16
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF </italic>
###xml 76 92 76 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF </italic>
###xml 356 364 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 402 404 402 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trxB</italic>
###xml 688 690 667 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 734 742 713 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 822 829 801 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 880 901 859 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis aroF </italic>
###xml 1196 1198 1175 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1220 1222 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 76 91 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 356 363 <span type="species:ncbi:562">E. coli</span>
###xml 402 406 <span type="species:ncbi:1773">MtCS</span>
###xml 688 692 <span type="species:ncbi:1773">MtCS</span>
###xml 734 741 <span type="species:ncbi:562">E. coli</span>
###xml 822 829 <span type="species:ncbi:562">E. coli</span>
###xml 880 895 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1196 1200 <span type="species:ncbi:1773">MtCS</span>
PCR amplification of Rv2540c DNA sequence (putative aroF gene) from genomic M. tuberculosis DNA yielded a fragment with the expected length (1206 bp). The fragment was cloned into pET23a(+) expression vector, and the aroF gene was sequenced, which confirmed its identity and the absence of PCR (Polymerase Chain Reaction)-introduced mutations. A number of E. coli host strains were employed to express MtCS, including BL21(DE3), Origami(DE3), and BL21trxB(DE3), but no expression could be obtained. Different cultivating temperatures (25degrees, 30degrees and 37degreesC) and presence or absence of isopropyl beta-D-thiogalactoside (IPTG) were also employed to no avail (data not shown). MtCS overexpression could only be achieved in E. coli Rosetta(DE3) host cells, which provide tRNAs for codons that are rarely used by E. coli. In agreement, ten rare codons were identified on M. tuberculosis aroF sequence (7 x CCC, AUA, CUA, GGA). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis revealed a cell extract containing a significant amount of a soluble protein with an apparent molecular weight in agreement with the predicted value based on amino acid sequence for MtCS (41.8 kDa) (Figure 2A).
###end p 16
###begin p 17
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 195 198 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac</italic>
###xml 449 451 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 502 517 496 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 529 536 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arabino</italic>
###xml 638 640 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 711 713 705 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 827 829 821 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 847 849 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 856 858 850 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1077 1079 1071 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1340 1342 1334 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 62 69 <span type="species:ncbi:562">E. coli</span>
###xml 502 517 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 711 715 <span type="species:ncbi:1773">MtCS</span>
###xml 827 831 <span type="species:ncbi:1773">MtCS</span>
###xml 856 860 <span type="species:ncbi:1773">MtCS</span>
###xml 1077 1081 <span type="species:ncbi:1773">MtCS</span>
###xml 1340 1344 <span type="species:ncbi:1773">MtCS</span>
Interestingly, recombinant protein expression was achieved in E. coli Rosetta(DE3) host cells grown for 24 h at 37degreesC in the absence of IPTG induction. It has been previously shown that the lac-controlled systems, including the pET system, could have a high-level protein expression, in the absence of inducer. This phenomenon occurs in the cell stationary phase, when there is the presence of a complex medium, cyclic AMP, acetate and low pH [19]. Recently, another shikimate pathway enzyme from M. tuberculosis, 3-Deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase, was reported to be expressed only in the absence of IPTG [20]. The three-step purification protocol yielded approximately 55 mg of MtCS from 6 liters of cell culture. No other protein can be observed on SDS-PAGE, which indicates the high level of MtCS purity (Figure 2B). The MtCS activity before the purification can hardly be measured, probably due to interfering compounds, and thus only the amount of total recombinant protein could be assessed. The ammonium sulfate precipitation of purified MtCS resulted in total inactivation of the enzyme (data not shown). Homogeneous recombinant protein was thus instantaneously frozen in liquid nitrogen in the absence of ammonium sulfate, which proved to be a convenient protocol for active homogeneous recombinant MtCS protein storage.
###end p 17
###begin p 18
###xml 12 14 12 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Recombinant <italic>Mt</italic>CS protein expression and purification</bold>
###xml 54 58 54 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF</italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF; </italic>
###xml 462 466 462 466 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 500 502 500 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 12 16 <span type="species:ncbi:1773">MtCS</span>
###xml 70 74 <span type="species:ncbi:1773">MtCS</span>
###xml 92 99 <span type="species:ncbi:562">E. coli</span>
###xml 500 504 <span type="species:ncbi:1773">MtCS</span>
Recombinant MtCS protein expression and purification. (A) Analysis of MtCS expression using E. coli Rosetta(DE3) host cells by SDS-poliacrilamide gel 12%. Lanes: 1 - pellet Rosetta(DE3)+pET23a(+)::aroF; 2 - soluble extract Rosetta(DE3)+pET23a(+)::aroF; 3 - pellet Rosetta(DE3)+pET23a(+) (negative control); 4 - soluble extract Rosetta(DE3)+pET23a(+) (negative control); 5 - protein molecular weight standards, high range (Gibco) (43 kDa; 29 kDa; 18 kDa; 14 kDa) (B) Analysis of purification steps of MtCS by SDS-polyacrylamide gel 12%. Lanes: 1 - soluble extract after dialysis; 2 - soluble extract after Q Sepharose Fast Flow column; 3 - CS after Phenyl-Sepharose column; 4 - CS after MonoQ column; 5 - protein molecular weight standards, high range (Gibco) (200 kDa; 97 kDa; 68 kDa; 43 kDa; 29 kDa; 18 kDa; 14 kDa).
###end p 18
###begin title 19
###xml 21 23 21 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 21 25 <span type="species:ncbi:1773">MtCS</span>
Analysis of purified MtCS
###end title 19
###begin p 20
###xml 26 28 26 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 264 266 264 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 422 424 422 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 26 30 <span type="species:ncbi:1773">MtCS</span>
###xml 264 268 <span type="species:ncbi:1773">MtCS</span>
###xml 422 426 <span type="species:ncbi:1773">MtCS</span>
The ESI-MS of homogeneous MtCS revealed a subunit molecular mass of 41,804 Da, consistent with the theoretical molecular mass (41,792 Da). The first 16 N-terminal amino acid residues were identified as MLRWITAGESHGRALV, which confirmed the identity of homogeneous MtCS and presence of N-terminal methionine residue. Analytical gel filtration chromatography revealed a single peak of approximately 104 kDa, suggesting that MtCS is a dimer in solution, which is in agreement with the hydrodynamic properties of the recombinant protein assessed by sedimentation velocity and sedimentation equilibrium [18].
###end p 20
###begin title 21
###xml 19 21 19 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 19 23 <span type="species:ncbi:1773">MtCS</span>
The CS activity of MtCS
###end title 21
###begin p 22
###xml 71 73 71 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 80 82 80 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 458 460 458 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 574 576 574 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 649 651 649 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 956 958 956 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1254 1257 1254 1257 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 1299 1301 1299 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1469 1471 1469 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1512 1514 1512 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1528 1530 1528 1530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1607 1625 1607 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurospora crassa </italic>
###xml 1629 1631 1629 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nc</italic>
###xml 1643 1645 1643 1645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1648 1650 1648 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1731 1735 1731 1735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red </sub>
###xml 1856 1857 1856 1857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1915 1935 1915 1935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 1936 1938 1936 1938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1944 1969 1944 1969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 1970 1972 1970 1972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2121 2123 2121 2123 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 2127 2131 2127 2131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red </sub>
###xml 2222 2224 2222 2224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nc</italic>
###xml 2264 2267 2264 2267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red</sub>
###xml 2271 2274 2271 2274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 2304 2307 2304 2307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 2381 2383 2381 2383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 574 578 <span type="species:ncbi:1773">MtCS</span>
###xml 649 653 <span type="species:ncbi:1773">MtCS</span>
###xml 956 960 <span type="species:ncbi:1773">MtCS</span>
###xml 1299 1303 <span type="species:ncbi:1773">MtCS</span>
###xml 1512 1516 <span type="species:ncbi:1773">MtCS</span>
###xml 1607 1624 <span type="species:ncbi:5141">Neurospora crassa</span>
###xml 1915 1934 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 1944 1968 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
The synthesis of EPSP was carried out in a vial containing the enzymes MtSK and MtEPSPS, which convert shikimate, ATP and phosphoenolpyruvate (PEP) to 5-enolpyruvylshikimate-3-phosphate (EPSP), ADP and Pi. The equilibrium of the forward reaction was displaced using Purine Nucleoside Phosphorylase (PNP), which consumes Pi, increasing the final concentration of EPSP in the reaction mixture. The enzymes were removed by ultrafiltration to avoid any residual MtEPSPS enzyme activity that could release Pi in solution, which would thus interfere with specific measurements of MtCS enzyme activity. Conversion of EPSP to chorismate and Pi catalyzed by MtCS enzyme activity (Figure 1) was determined by measuring the release of Pi using PNP, which converts 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) and Pi to ribose-1-phosphate and 7-methyl-6-thio-guanine base, monitoring absorbance of the latter at 360 nm. The enzymatic activity of homogenous MtCS was dependent on enzyme volume added to the reaction mixture (data not shown), showing that the initial velocity is proportional to total enzyme concentration and that true initial velocities are being measured. The conversion of EPSP to chorismate in aerobic conditions by the addition of FMNox and NADH is the first solid evidence that MtCS is bifunctional, since the monofunctional CSs can only be assayed under strictly anaerobic conditions in the presence of chemically or enzymatically reduced flavin [16]. The specific activity of bifunctional MtCS (0.004 U.mg-1) is approximately 175-fold lower than the specific activity of bifunctional Neurospora crassa CS (NcCS; 0.7 U.mg-1) [21]. In the presence of oxygen the CS activity is limited by the reoxidation of FMNred cofactor; but in bifunctional CSs, NAD(P)H is used in consecutive cycles to maintain the FMN in its reduced form (Figure 1). Moreover, the structures of CS complexed with FMN from Helicobacter pylori [22] and Streptococcus pneumoniae [23] have shown that there are a number of positively charged amino acids in the FMN binding pocket, which could increase the reduction potential of FMNox/FMNred couple, likely permitting the decrease of the rate of reoxidation. Indeed, in bifunctional NcCS the redox potential of the couple FMNred/FMNox was determined to be -167 mV, i.e. 40 mV more positive than that of the free couple in solution (-207 mV) [24].
###end p 22
###begin title 23
###xml 40 42 40 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 40 44 <span type="species:ncbi:1773">MtCS</span>
The NADH:FMN-oxidoreductase activity of MtCS
###end title 23
###begin p 24
###xml 35 38 35 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 400 402 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 408 411 408 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 420 422 420 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 454 457 454 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 811 813 811 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 885 887 885 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 955 957 955 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1026 1029 1026 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 1078 1079 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1115 1117 1115 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1127 1130 1127 1130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 173 177 <span type="species:ncbi:1773">MtCS</span>
###xml 400 404 <span type="species:ncbi:1773">MtCS</span>
###xml 420 424 <span type="species:ncbi:1773">MtCS</span>
###xml 811 815 <span type="species:ncbi:1773">MtCS</span>
###xml 885 889 <span type="species:ncbi:1773">MtCS</span>
###xml 955 959 <span type="species:ncbi:1773">MtCS</span>
###xml 1115 1119 <span type="species:ncbi:1773">MtCS</span>
The NADH-dependent reduction of FMNox was measured in the forward reaction monitoring the decrease in NADH concentration. The NADH:FMN-oxidoreductase activity of homogenous MtCS is dependent on the enzyme volume added to the reaction mixture; therefore the initial velocity is proportional to total enzyme concentration, and true initial velocities are being measured. To verify the stability of the MtCS-FMNox complex, MtCS was incubated with excess FMNox and loaded on an anion exchange column. Two peaks were observed and collected into separated fractions measuring absorbance at 280 nm and 445 nm, and pooled (Figure 3). To roughly estimate the presence of protein in the two pools, coomassie-blue was added to them and only the second pool was shown to contain protein (indicating presence of recombinant MtCS), while the first was not stained (indicating absence of recombinant MtCS). The UV-Vis spectrum for the second pool containing recombinant MtCS protein showed that all the characteristic absorbance peaks of FMNox (267, 373, and 445 nm) could be observed (Figure 3 inset). These results suggest that MtCS and FMNox form a stable binary complex.
###end p 24
###begin p 25
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Elution profile of incubated <italic>Mt</italic>CS and FMNox, and UV-Vis spectrum showing stable binary complex formation</bold>
###xml 117 119 117 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 129 131 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 338 340 338 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 377 379 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 385 388 385 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 541 544 541 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 29 33 <span type="species:ncbi:1773">MtCS</span>
###xml 117 121 <span type="species:ncbi:1773">MtCS</span>
###xml 377 381 <span type="species:ncbi:1773">MtCS</span>
Elution profile of incubated MtCS and FMNox, and UV-Vis spectrum showing stable binary complex formation. Elution of MtCS and FMNoxincubation in a HiTrapQ HP column upon a linear gradient from 0 to 1 M NaCl (dashed line). The absorbance was monitored at 445 nm (dotted line) and 280 nm (solid line). The first peak corresponds to free FMNox, and the second peak corresponds to MtCS-FMNox complex. Inset: UV-Vis spectrum ranging from 210 nm to 600 nm of the second pool (solid line) and Tris-HCl (dotted line). All characteristic peaks of FMNox can be observed (267 nm, 373 nm, and 445 nm).
###end p 25
###begin p 26
###xml 16 19 16 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 143 145 143 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 257 259 257 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 288 291 288 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 408 410 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 495 497 494 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nc</italic>
###xml 506 509 505 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 510 512 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 543 545 542 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 658 660 657 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 806 808 804 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 993 995 991 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1086 1088 1084 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1094 1097 1092 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 1133 1135 1131 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1161 1164 1159 1162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 143 147 <span type="species:ncbi:1773">MtCS</span>
###xml 221 228 <span type="species:ncbi:562">E. coli</span>
###xml 543 547 <span type="species:ncbi:1773">MtCS</span>
###xml 658 662 <span type="species:ncbi:1773">MtCS</span>
###xml 806 810 <span type="species:ncbi:1773">MtCS</span>
###xml 993 997 <span type="species:ncbi:1773">MtCS</span>
###xml 1086 1090 <span type="species:ncbi:1773">MtCS</span>
###xml 1133 1137 <span type="species:ncbi:1773">MtCS</span>
Although the FMNox usually appears as a prosthetic group in NAD(P)H:FMN oxidoreductases from other organisms [25], it was not clear whether in MtCS the FMN is covalently bound. CSs from other organisms, such as that from E. coli, showed low affinity for FMNox; but the value of Kd for FMNox depends strongly on EPSP binding, decreasing ca. 1000-fold in the presence of this substrate (from 30 muM to 20 nM) [26]. On the other hand, EPSP has a much smaller effect on the affinity of bifunctional NcCS to FMNox [21]. Interestingly, the purified MtCS is FMN-free, which could be an effect of the insufficient intracellular concentration of FMN, probably due to MtCS overexpression into the host cell. As described below, FMN appears to have a value lower than 20 muM for the overall dissociation constant for MtCS-FMN binary complex formation at equilibrium. Accordingly, it appears to be more likely that FMN is lost during the protein purification protocol because of a rather weak affinity of MtCS for FMN. Accordingly, the kinetic data were collected considering the holoenzyme as the MtCS-FMNox complex brought about by incubating MtCS and near-saturating FMNox concentration.
###end p 26
###begin p 27
###xml 201 203 201 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 564 566 563 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 578 581 577 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 672 673 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 746 747 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 747 752 746 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NADH </sub>
###xml 768 769 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 769 773 765 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat </sub>
###xml 793 796 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3 </sup>
###xml 797 800 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 804 805 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 805 808 799 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 809 810 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 810 815 804 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NADH </sub>
###xml 822 825 816 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 826 828 820 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 834 835 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 835 840 829 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NADH </sub>
###xml 853 855 847 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 876 877 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 877 883 871 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NADPH </sub>
###xml 898 900 892 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nc</italic>
###xml 904 906 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 912 914 906 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sc</italic>
###xml 918 920 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1126 1127 1118 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 1127 1135 1119 1127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NAD(P)H </sub>
###xml 1160 1185 1151 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rhodococcus erythropolis </italic>
###xml 1186 1188 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1205 1223 1195 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis </italic>
###xml 1224 1226 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 201 205 <span type="species:ncbi:1773">MtCS</span>
###xml 564 568 <span type="species:ncbi:1773">MtCS</span>
###xml 853 857 <span type="species:ncbi:1773">MtCS</span>
###xml 1160 1184 <span type="species:ncbi:1833">Rhodococcus erythropolis</span>
###xml 1205 1222 <span type="species:ncbi:1423">Bacillus subtilis</span>
The oxidoreductase activity is functionally independent of CS activity, since the consumption of NADH occurs in the absence of EPSP. Considering the low specific activity of NADH:FMN-oxidoreductase in MtCS, all measurements were made in triplicate, including the controls. Accordingly, the apparent kinetic parameters for the oxidoreductase activity were determined in the absence of EPSP in steady-state kinetic experiments. No activity was observed when NADPH was used at concentrations ranging from 100 to 500 muM (data not shown). Kinetics of reduction of the MtCS-bound FMNox by NADH was determined using fixed amount of holoenzyme and varying levels of NADH (Figure 4). The data were fitted to equation 1, and yielded the following values: KNADH = 36 +/- 4 muM, kcat = 8.3 (+/- 0.3) x 10-3 s-1 and kcat/KNADH = 231 M-1 s-1. The KNADH observed for MtCS is similar to the KNADPH determined for NcCS [24] and ScCS [27] (43 muM and 70 muM, respectively). In other NAD(P)H:FMN oxidoreductases (EC 1.5.1.30), which are present in various organisms, the apparent kinetic constants show significant variation. For instance, the KNAD(P)H can vary from 208 muM in Rhodococcus erythropolis [28] to 0.85 muM in Bacillus subtilis [29].
###end p 27
###begin p 28
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Determination of steady-state kinetic parameters</bold>
###xml 113 115 113 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 121 124 121 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 317 318 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 318 323 317 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NADH </sub>
###xml 339 340 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 340 344 336 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat </sub>
###xml 364 367 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3 </sup>
###xml 368 371 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 375 376 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 376 379 370 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 380 381 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 381 386 375 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NADH </sub>
###xml 393 396 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 397 399 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 113 117 <span type="species:ncbi:1773">MtCS</span>
Determination of steady-state kinetic parameters. Double-reciprocal plot of initial velocity data for holoenzyme MtCS-FMNox in the presence of varying concentration of NADH (10, 25, 50, 75, 100, 200, 300 muM). Inset: Michaelis-Menten representation. The data were fitted to equation 1, yielding the following values: KNADH = 36 +/- 4 muM, kcat = 8.3 (+/- 0.3) x 10-3 s-1 and kcat/KNADH = 231 M-1 s-1.
###end p 28
###begin title 29
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 54 56 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 54 58 <span type="species:ncbi:1773">MtCS</span>
Equilibrium measurements of FMNox and NADH binding to MtCS
###end title 29
###begin p 30
###xml 18 21 18 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 24 26 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 250 253 249 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 261 262 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 271 274 270 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 401 402 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 444 447 442 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 691 694 687 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 793 796 789 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 870 872 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 941 943 937 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 974 976 970 972 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 1051 1054 1047 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 1065 1067 1061 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1140 1142 1136 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1148 1151 1144 1147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 24 28 <span type="species:ncbi:1773">MtCS</span>
###xml 941 945 <span type="species:ncbi:1773">MtCS</span>
###xml 1065 1069 <span type="species:ncbi:1773">MtCS</span>
###xml 1140 1144 <span type="species:ncbi:1773">MtCS</span>
The binding of FMNox to MtCS was assessed by UV-visible difference spectra as described by Kitzing et al. [21]. The observed spectral changes are characterized by hypochromic effects on the flavin absorbance at both 378 nm and 450 nm up to 20 muM FMNox (Figure 5). At FMNox concentrations larger than 30 muM there is a hyperchromic effect that is probably due to free oxidized FMN in solution (Figure 5 - inset). The spectral changes at low FMNox concentrations yielded low values for the difference spectra and thus no reliable data could be obtained at concentrations lower than 10 muM. Accordingly, the data presented here allow only to estimate an upper limit value of 20 muM for the FMNox equilibrium dissociation constant. We have also tried to determine the dissociation constant of FMNox from protein fluorescence titration as recently described by Broco et al [30], which could allow reliable measurement of oxidized FMN binding to MtCS at low concentrations of FMNox. However, there was no quench/enhancement in protein fluorescence upon FMNox binding to MtCS (data not shown). At any rate, the UV-visible difference spectra show MtCS-FMNox binary complex formation.
###end p 30
###begin p 31
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">UV-visible difference spectroscopy</bold>
###xml 170 172 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 200 202 198 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 234 236 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 264 266 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 298 300 293 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 334 336 328 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 368 370 361 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 427 429 419 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 170 174 <span type="species:ncbi:1773">MtCS</span>
###xml 200 204 <span type="species:ncbi:1773">MtCS</span>
###xml 264 268 <span type="species:ncbi:1773">MtCS</span>
###xml 334 338 <span type="species:ncbi:1773">MtCS</span>
UV-visible difference spectroscopy. Difference absorbance spectra were recorded from 300 to 600 nm. The difference spectra are as follows: dash-dotted line (-.-), 35 muM MtCS; solid line (--), 35 muM MtCS in the presence of 10 muM FMNox; dashed line (- -), 35 muM MtCS in the presence of 20 muM FMNox; and dotted line (.....), 35 muM MtCS in the presence of 30 muM FMNox. The inset shows absorbance spectrum of 100 muM free FMNox.
###end p 31
###begin p 32
###xml 35 37 35 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 146 148 146 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 260 262 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 531 533 528 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 35 39 <span type="species:ncbi:1773">MtCS</span>
###xml 146 150 <span type="species:ncbi:1773">MtCS</span>
###xml 260 264 <span type="species:ncbi:1773">MtCS</span>
###xml 531 535 <span type="species:ncbi:1773">MtCS</span>
The equilibrium binding of NADH to MtCS was assessed by fluorescence spectroscopy. There is a quench in protein fluorescence upon NADH binding to MtCS (Figure 6 - inset). A titration curve showing the quench in protein fluorescence upon the binding of NADH to MtCS is given in Figure 6. The data were fitted to a hyperbolic equation yielding a dissociation constant value of 156 +/- 12 muM. Even though the NADH-binding site remains unknown, the results presented here clearly indicate that there is indeed an NADH binding site on MtCS enzyme.
###end p 32
###begin p 33
###xml 31 33 31 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 0 120 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Equilibrium binding of NADH to <italic>Mt</italic>CS assessed by monitoring the protein fluorescence quench upon binary complex formation</bold>
###xml 145 147 145 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 197 201 192 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">exc </sub>
###xml 225 228 213 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">em </sub>
###xml 273 275 259 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 497 499 482 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 660 662 643 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 31 35 <span type="species:ncbi:1773">MtCS</span>
###xml 145 149 <span type="species:ncbi:1773">MtCS</span>
###xml 273 277 <span type="species:ncbi:1773">MtCS</span>
###xml 497 501 <span type="species:ncbi:1773">MtCS</span>
###xml 660 664 <span type="species:ncbi:1773">MtCS</span>
Equilibrium binding of NADH to MtCS assessed by monitoring the protein fluorescence quench upon binary complex formation. The binding of NADH to MtCS causes a quench in protein fluorescence (lambdaexc = 290 nm; 310 </= lambdaem </= 510 nm; with a maximum at 345.5 nm). The MtCS enzyme solution (1 muM) was titrated with increasing concentrations of NADH, and the data points (fluorescence intensities at 345.5 nm) were fitted to a hyperbolic equation (solid line). Inset: Emission spectra of free MtCS (1 muM) and enzyme in the presence of 80 muM NADH. Emission spectrum of free enzyme shows a peak at 345.5 nm and no emission at ~450 nm. Emission spectrum of MtCS in the presence of NADH shows a quench in protein fluorescence concomitant to an increase in nucleotide fluorescence at ~450 nm.
###end p 33
###begin title 34
Primary deuterium kinetic isotope effects
###end title 34
###begin p 35
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 203 204 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 315 316 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 316 318 312 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 322 323 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 323 326 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K</italic>
###xml 384 385 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 386 387 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 428 429 424 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 430 435 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">proS </italic>
###xml 492 495 488 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 508 510 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 533 535 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 629 631 625 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 637 639 633 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 778 782 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K </italic>
###xml 923 925 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1028 1030 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1293 1295 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1302 1303 1298 1299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 1303 1305 1299 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 1324 1326 1320 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1332 1335 1328 1331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 1484 1485 1480 1481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 1485 1489 1481 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K </italic>
###xml 1530 1531 1526 1527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 1531 1535 1527 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K </italic>
###xml 1582 1584 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1869 1871 1865 1867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 508 512 <span type="species:ncbi:1773">MtCS</span>
###xml 629 633 <span type="species:ncbi:1773">MtCS</span>
###xml 1324 1328 <span type="species:ncbi:1773">MtCS</span>
To probe for rate-limiting steps and determine the stereospecificity of hydride transfer, primary deuterium kinetic isotope effects were determined. Initial velocity data were collected using either [4S-1H]NADH or [4S-2H]NADH (Figure 7), and values of 3.5 +/- 0.2 and 3.0 +/- 0.4 were determined for, respectively, DV and DV/K. The magnitude of the primary isotope effects when the [4S-2H]NADH substrate is used indicates that C4-proS hydrogen is being transferred during the reduction of FMNox catalyzed by MtCS. Isotope effects on V are related to events following the formation of the complex capable of undergoing catalysis (MtCS-FMNox-NADH in the case studied here), including chemical steps, possible enzyme conformational changes, and product release. Isotope effects on V/K report on steps in the reaction mechanism from the binding of the labeled substrate to the first irreversible step, usually product release [31]. The values for primary deuterium isotope effects of biochemical interest usually range from 3 to 7 [32], and steps such as conformational changes accompanying hydride transfer and product release may account for the lower values. In particular, primary deuterium kinetic isotope effects typically range from 1 to 3 for enzyme reactions involving NAD(P)H oxidation [33]. The DV value obtained for MtCS-FMNox (3.5) suggests that the hydride transfer contributes significantly to the rate-limiting step of the FMN reduction reaction. The value of 3.0 for the DV/K indicates that NADH is not sticky, since DV/K values for sticky substrates are around unity [34]. It should be remembered that a substrate is sticky if it reacts to give products as fast as, or faster than, it dissociates from the enzyme. The stickiness of a substrate depends on the external part of its commitment: the larger the external commitment, the sticker the substrate [34].
###end p 35
###begin p 36
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Primary and multiple deuterium kinetic isotope effects</bold>
###xml 118 120 118 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 188 189 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 189 191 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 195 196 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 196 199 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K</italic>
###xml 261 262 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 325 328 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 328 329 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 331 332 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 329 341 321 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">[4<italic>S</italic>-2H]NADH </sub>
###xml 345 348 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 348 351 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K</italic>
###xml 351 362 343 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">[4S-2H]NADH</sub>
###xml 388 389 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 390 391 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 407 408 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 409 410 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 478 479 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 480 481 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 493 494 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 495 496 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 118 122 <span type="species:ncbi:1773">MtCS</span>
Primary and multiple deuterium kinetic isotope effects. Measurements of primary deuterium kinetic isotope effects for MtCS yielded values of 3.5 +/- 0.2 and 3.0 +/- 0.4 for, respectively, DV and DV/K. Inset: Measurements of primary isotope effect in 90 atom % D2O (multiple) yielded values of 1.3 +/- 0.1 and 2.2 +/- 0.1 for D2OV[4S-2H]NADH and D2OV/K[4S-2H]NADH, respectively. In both [4S-1H]NADH (●) or [4S-2H]NADH (■) is varied in the reaction mixture. L represents either [4S-1H]NADH or [4S-2H]NADH.
###end p 36
###begin title 37
Solvent isotope effects and proton inventory
###end title 37
###begin p 38
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 265 268 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 268 270 264 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 274 277 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 277 280 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K</italic>
###xml 544 546 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 585 586 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 648 650 644 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 676 677 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 700 701 696 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 814 816 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
Solvent isotope effects were employed to assess the contribution of solvent proton transfer to the rate of flavin reduction. Initial velocity data were collected in either H2O or 91 atom % D2O (Figure 8), and values of 1.7 +/- 0.3 and 1.3 +/- 0.1 were obtained for D2OV and D2OV/K, respectively. The magnitude of the solvent isotope effects indicate that proton transfer partially limit the rate of FMN reduction reaction. In order to determine the number of kinetically important protons transferred during the reaction, a proton inventory on V was carried out. The mole fraction of D2O was varied from 0 to 80%, and a linear relationship between V and the mole fraction of D2O was observed (Figure 8, inset). This result indicates that a single proton transfer gives rise to the observed solvent isotope effect [35].
###end p 38
###begin p 39
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Solvent deuterium kinetic isotope effects and proton inventory</bold>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 179 180 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 239 242 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 242 244 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 248 251 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 251 254 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K</italic>
###xml 92 96 <span type="species:ncbi:1773">MtCS</span>
Solvent deuterium kinetic isotope effects and proton inventory. Solvent isotope effects for MtCS. NADH is varied in the reaction mixture containing either 0 (●) or 91 (■) atom % D2O. Values of 1.7 +/- 0.3 and 1.3 +/- 0.1 were obtained for D2OV and D2OV/K, respectively. Inset: Proton inventory at saturating concentration of NADH, indicating that a single proton transfer from solvent contribute to the rate of flavin reduction.
###end p 39
###begin title 40
Multiple isotope effects
###end title 40
###begin p 41
###xml 221 235 221 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pneumoniae </italic>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 277 279 277 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D</sup>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K </italic>
###xml 352 355 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 355 357 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K </italic>
###xml 525 527 525 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 852 853 852 853 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 871 872 871 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1005 1006 1005 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1229 1232 1229 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 1258 1261 1258 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 1274 1276 1274 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1441 1444 1437 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 1444 1445 1440 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 1447 1448 1443 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1445 1457 1441 1453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">[4<italic>S</italic>-2H]NADH </sub>
###xml 1461 1464 1457 1460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D2O</sup>
###xml 1464 1467 1460 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K</italic>
###xml 1469 1470 1465 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1467 1478 1463 1474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">[4<italic>S</italic>-2H]NADH</sub>
###xml 1501 1502 1497 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1566 1568 1562 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 1572 1576 1568 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K </italic>
###xml 1580 1581 1576 1577 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1617 1618 1613 1614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1685 1687 1681 1683 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 1718 1720 1714 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nc</italic>
###xml 1783 1787 1779 1783 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red </sub>
###xml 2001 2004 1997 2000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro</italic>
###xml 2141 2143 2137 2139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2183 2185 2179 2181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nc</italic>
###xml 2330 2334 2326 2330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red </sub>
###xml 2373 2376 2369 2372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro</italic>
###xml 2397 2399 2393 2395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2519 2535 2515 2531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 2561 2563 2557 2559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2678 2680 2674 2676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2756 2758 2752 2754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2828 2830 2824 2826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 221 234 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 525 529 <span type="species:ncbi:1773">MtCS</span>
###xml 1274 1278 <span type="species:ncbi:1773">MtCS</span>
###xml 2519 2534 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2828 2832 <span type="species:ncbi:1773">MtCS</span>
Significantly different magnitudes between primary and solvent kinetic isotope effects may indicate that they are reporting on distinct steps of a reaction, as reported for the NADPH-dependent ketoacyl-ACP reductase from S. pneumoniae [36]. The primary isotope effect values (DV = 3.5 and DV/K = 3.0) are larger than those for solvent isotope effects (D2OV = 1.7 and D2OV/K = 1.3), suggesting that proton and hydride transfer may take place in two distinct transition-states, with the latter being more rate-limiting for the MtCS-catalyzed reaction. Multiple isotope effects studies are able to distinguish whether two different isotopic substitutions affect the same or different chemical steps. Theory predicts that if protonation and hydride transfer occur in the same transition state, the primary isotope effects will be larger or unchanged with D2O as compared to H2O. On the other hand, if hydride transfer and protonation occur in distinct steps, the primary isotope effects will be smaller with D2O as solvent, as proton transfer will become more rate limiting [37,38]. Multiple isotope effects were thus evaluated to distinguish whether two different isotopic substitutions affect the same or different chemical steps, i.e., if the reduction of FMNox catalyzed by MtCS occurs, respectively, in a concerted or in a stepwise mechanism. Initial velocity data were collected and values of 1.3 +/- 0.1 and 2.2 +/- 0.1 were obtained for D2OV[4S-2H]NADH and D2OV/K[4S-2H]NADH, respectively (Figure 7, inset). The values for the primary kinetic isotope effects on V and V/K in D2O were smaller than the effects in H2O, thereby suggesting a stepwise mechanism for the reduction of FMNox. A mechanism for bifunctional NcCS has been proposed and involves an electron transfer from FMNred to C1 EPSP and C-O bond cleavage, protonation of the leaving phosphate group by His17, tautomerization of the resulting C4(a)-neutral flavin semiquinone to a radical species with concomitant abstraction of the C-(6proR) hydrogen of the dephosphorylated substrate intermediate, and reduced flavin deprotonation restores the initial state of the cofactor [24]. More recently, it has been shown for NcCS that the carboxylate group of Asp367 participates in the water-mediated deprotonation of the N(5) atom of the isoalloxazine ring system of FMNred that is involved in abstraction of C-(6proR) hydrogen of EPSP [39]. A comparison of the primary sequences of CSs from different sources has shown that these residues (His11 and Asp343, M. tuberculosis numbering) are conserved [18]. Interestingly, His11 and Asp343 are present in monofunctinal and bifunctional CSs and across all known species [40], and these residues are part of the characteristic CS signature sequence [23]. The role of His11 and Asp343 in the mode of action of bifunctional MtCS should await site-directed mutagenesis studies that are currently underway in our laboratory.
###end p 41
###begin title 42
Conclusion
###end title 42
###begin p 43
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 360 362 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 407 432 407 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 740 742 740 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 906 908 906 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1005 1007 1005 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1023 1024 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1025 1030 1025 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">proS </italic>
###xml 1081 1083 1081 1083 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 1446 1448 1446 1448 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 1616 1632 1616 1632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1642 1644 1642 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1803 1805 1803 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1906 1908 1906 1908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 2073 2078 2073 2078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF </italic>
###xml 2086 2101 2086 2101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 2168 2170 2168 2170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 2247 2249 2247 2249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 360 364 <span type="species:ncbi:1773">MtCS</span>
###xml 407 431 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 740 744 <span type="species:ncbi:1773">MtCS</span>
###xml 906 910 <span type="species:ncbi:1773">MtCS</span>
###xml 1005 1009 <span type="species:ncbi:1773">MtCS</span>
###xml 1616 1631 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1906 1910 <span type="species:ncbi:1773">MtCS</span>
###xml 2086 2101 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2168 2172 <span type="species:ncbi:1773">MtCS</span>
###xml 2247 2251 <span type="species:ncbi:1773">MtCS</span>
It has recently been pointed out that we are currently unable to predict bifuncionality based on sequence information and three-dimensional structures available at present because of difficulties in identifying the NAD(P)H-binding site of bifunctional CSs [40]. Incidentally, the three-dimensional structural model [41] and X-ray diffraction structure [18] of MtCS employed the crystal structure of CS from Streptococcus pneumoniae [23] as template, which is a monofunctional CS. It is thus necessary to measure CS enzyme activity to show whether it depends on a source of free reduced FMN (monofunctional) or can directly reduce FMN cofactor at the expense of NAD(P)H (bifunctional). Here we present experimental evidence that recombinant MtCS is bifunctional. To the best of our knowledge, this is the first report showing that a bacterial CS is bifunctional. We also show that FMN and NADH bind to free MtCS. Primary deuterium kinetic isotope effects of the NADH-dependent flavin reductase activity of MtCS showed that C4-proS hydrogen is transferred during the reduction of FMNox, and that hydride transfer contributes significantly to the rate-limiting step of FMN reduction. Solvent deuterium kinetic isotope effects suggest that proton transfer from solvent partially limits the rate of FMN reduction and that a single proton is transferred from solvent. Multiple isotope effects indicate that a stepwise mechanism for the reduction of FMNox. Expression of functional proteins in soluble form has been identified as an important bottleneck in efforts to determine biological activity and crystal structure of M. tuberculosis proteins [42]. Moreover, protein purification has become an important asset in any structural genomic effort as there has been increasing demand for homogeneous proteins [43]. Accordingly, the work presented here should contribute to overcome these obstacles for, at least, MtCS and allow functional and structural efforts to be pursued. We provide experimental evidence for the correct assignment of the Rv2540c DNA sequence as a CS-coding aroF gene in M. tuberculosis, which is a pivotal step for the rational design of inhibitors of MtCS enzyme activity with potential antitubercular action. The availability of MtCS and the experimental evidence given here for an NADH-binding site warrant further efforts to obtain the crystal structure of the binary complex to try to elucidate the structural features of this interaction and the mechanism of action for bifunctional CSs. The results reported here should thus pave the way for further functional and structural studies to guide the rational design of antitubercular agents.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
Chemical, reagents, enzymes and bacterial strains
###end title 45
###begin p 46
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu </italic>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 465 467 465 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 502 528 502 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Leuconostoc mesenteroides </italic>
###xml 76 83 <span type="species:ncbi:562">E. coli</span>
###xml 502 527 <span type="species:ncbi:1245">Leuconostoc mesenteroides</span>
###xml 579 584 <span type="species:ncbi:4932">yeast</span>
Pfu DNA polymerase was from Stratagene. The pET23a(+) expression vector and E. coli Rosetta(DE3) host cell were from Novagen. All chromatographic supports, including the molecular weight calibration kits, were purchased from GE Healthcare. The protease inhibitor cocktail was from Roche. Purine nucleotide phosphorylase (PNP, EC 2.4.2.1) and 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) were purchased from Molecular Probes. NADH, NAD+, oxidized FMN (FMNox), ATP, phosphoenolpyruvate (PEP), Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase (type XXIII) and yeast hexokinase (type C-300) were from Sigma Chemical Co. D-glucose-1-d (97 atom % D) was from Aldrich and deuterium oxide (99.9 atom % D) was from Cambridge Isotope Laboratories.
###end p 46
###begin title 47
###xml 41 57 41 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF</italic>
###xml 41 56 <span type="species:ncbi:1773">M. tuberculosis</span>
Molecular cloning, and overexpression of M. tuberculosis Rv2540c (aroF) DNA sequence
###end title 47
###begin p 48
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF </italic>
###xml 142 148 142 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">catatg</bold>
###xml 179 185 179 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ggatcc</bold>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF</italic>
###xml 434 450 434 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu </italic>
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 616 619 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aroF </italic>
###xml 834 844 834 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(+)::aroF </italic>
###xml 884 892 884 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 967 970 966 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 997 1000 995 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 1279 1281 1268 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 280 295 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 434 449 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 884 891 <span type="species:ncbi:562">E. coli</span>
Synthetic oligonucleotide primers complementary to amino-terminal coding and carboxy-terminal noncoding strands of aroF (Rv2540c) gene (5' ggtcatatgttgcgctggatcaccgcgg 3' and 5' cggatcctcaaccggagacccgcgcggc 3', respectively) were designed based on the complete genome sequence of M. tuberculosis [13]. These primers, containing 5'NdeI and 3'BamHI restriction sites, in bold, were used to amplify aroF-CS encoding gene (1,206 bp) from M. tuberculosis genomic DNA, using Pfu DNA polymerase and standard PCR conditions. The amplified fragment was purified by low melting agarose electrophoresis, digested with NdeI and BamHI, and cloned into pET23a(+) expression vector previously digested with the same restriction enzymes. The aroF gene identity and the absence of PCR-introduced mutations were confirmed by DNA sequencing. The pET23a (+)::aroF was transformed by electroporation into E. coli Rosetta(DE3) host cells and selected on LB agar plates containing 50 mug.mL-1 carbenicillin and 34 mug.mL-1 chloramphenicol. Single colonies were used to inoculate 1 L of Luria-Bertani medium containing the same antibiotics and grown for 24 h at 37degreesC at 180 rpm with no isopropyl beta-D-thiogalactoside (IPTG) induction. The cells (4.5 g) were harvested by centrifugation at 3,000 g for 30 min at 4degreesC.
###end p 48
###begin title 49
###xml 12 14 12 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 12 16 <span type="species:ncbi:1773">MtCS</span>
Recombinant MtCS protein purification
###end title 49
###begin p 50
###xml 185 188 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 303 305 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 530 532 524 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 641 643 635 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 865 867 859 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1106 1107 1100 1101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1108 1109 1102 1103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1111 1112 1105 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1200 1201 1194 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1202 1203 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1205 1206 1199 1200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1506 1508 1500 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 1646 1648 1634 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1708 1710 1696 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 865 869 <span type="species:ncbi:1773">MtCS</span>
###xml 1506 1510 <span type="species:ncbi:1773">MtCS</span>
###xml 1759 1765 <span type="species:ncbi:9913">bovine</span>
All purification procedures were performed at 4degreesC. Cells (25 g) were suspended in 75 mL of 50 mM Tris-HCl, pH 7.8 (buffer A) containing proteinase inhibitor cocktail and 0.2 mg.mL-1 lisozyme; and the mixture was stirred for 30 min. The cells were disrupted by sonication and centrifuged at 48,000 g for 30 min to remove cell debris. Streptomycin sulfate was added to the supernantant to a final concentration of 1% (w/v) and the mixture was stirred for 30 min. The soluble fraction was collected by centrifugation at 48,000 g for 30 min and dialyzed 3 times against 2 L of buffer A. This sample was clarified by centrifugation (48,000 g for 30 min), loaded on a Q-Sepharose Fast Flow (2.6 cm x 8.2 cm) anion exchange column previously equilibrated with buffer A and the proteins eluted using a linear gradient from 0.0 to 0.5 M NaCl. The fractions containing MtCS were pooled and ammonium sulfate was added to a final concentration of 0.8 M. This sample was loaded on a High Load Phenyl-Sepharose (1.6 cm x 10 cm) hydrophobic interaction column pre-equilibrated with 50 mM Tris-HCl, pH 7.8, 0.8 M (NH4)2SO4(buffer B). The proteins were fractionated using a linear gradient from 0.8 to 0.0 M (NH4)2SO4. The active fractions were pooled and dialyzed 3 times against 2 L of buffer A. The sample was loaded on a MonoQ (1.6 cm x 10 cm) anion exchange column previously equilibrated with buffer A, and the proteins eluted using a linear gradient of NaCl (0.0 - 0.5 M). The fractions containing homogeneous MtCS were pooled, quickly frozen in liquid nitrogen and stored at -80degreesC. Samples of each purification step were analyzed by SDS-PAGE [44]. Protein concentration was determined by Bradford method [45], using Bio-Rad protein assay kit (Bio-Rad) and bovine serum albumin as standard.
###end p 50
###begin title 51
Mass spectrometry analysis and N-terminal amino acid sequencing
###end title 51
###begin p 52
###xml 12 14 12 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 294 296 293 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 467 470 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 504 506 497 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 696 698 689 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 761 763 754 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 12 16 <span type="species:ncbi:1773">MtCS</span>
###xml 549 554 <span type="species:ncbi:9796">horse</span>
###xml 696 700 <span type="species:ncbi:1773">MtCS</span>
###xml 761 765 <span type="species:ncbi:1773">MtCS</span>
Recombinant MtCS was analyzed using mass spectrometry in an adaptation of Chassaigne and Lobinski systems [46]. Samples were analyzed on a triple quadrupole mass spectrometer, model QUATRO II, equipped with a standard electrospray (ESI) probe (Micromass, Altrinchan) adjusted to ca. 250 muL.min-1. The source temperature (80degreesC) and needle voltage (3.6 kV) were maintained constant throughout the data collection, applying a drying gas flow (nitrogen) of 200 L.h-1 and a nebulizer gas flow of 20 L.h-1. The equipment was calibrated with intact horse heart myoglobin. Approximately 50 pmol of sample was injected into electrospray transport solvent to determine the subunit molecular mass of MtCS. The N-terminal amino acid residues of purified recombinant MtCS were identified by automated Edman degradation sequencing using a PPSQ 21A gas-phase sequencer (Shimadzu).
###end p 52
###begin title 53
###xml 24 26 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 24 28 <span type="species:ncbi:1773">MtCS</span>
Determination of native MtCS molecular mass
###end title 53
###begin p 54
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 169 171 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 29 33 <span type="species:ncbi:1773">MtCS</span>
The molecular mass of native MtCS was determined by gel filtration using Superdex S-200 (10 mm x 30 cm) column eluted with buffer A containing 200 muM NaCl at 0.4 mL.min-1. The protein elution was monitored at 280 nm. The protein molecular weight standards were from Low Molecular Weight and High Molecular Weight Calibration kits (GE Healthcare).
###end p 54
###begin title 55
EPSP synthesis
###end title 55
###begin p 56
###xml 104 106 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 129 131 129 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 143 159 143 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 344 345 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 431 433 425 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 443 445 437 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 143 158 <span type="species:ncbi:1773">M. tuberculosis</span>
Since there is no ESPS commercially available, EPSP was synthesized using the enzymes shikimate kinase (MtSK) and EPSP synthase (MtEPSPS) from M. tuberculosis [47,48], and PNP [49,50]. The synthesis was carried out using 9.6 mM shikimate, 2.4 mM ATP, 3 mM PEP, 0.4 mM MESG. This reaction mixture was pre-incubated in 50 mM Tris-HCl, 2.5 mM MgCl2, 2.5 mM KCl pH 7.6 for 3 min at 25degreesC. Then the three enzymes were added (2.2 U MtSK, 0.7 U MtEPSPS, 2 U PNP) and the reaction mixture was incubated further at 25degreesC for 30 min. The enzymes were then removed by ultrafiltration using a Centricon 3000 Da cut-off (Amicon). The filtrated solution, containing the substrate EPSP, was collected and used to measure chorismate synthase activity. The reaction catalyzed by EPSP synthase releases an inorganic phosphate molecule, which is consumed by PNP. This coupled reaction changes the equilibrium constant of ESPS synthase reaction, allowing synthesis of higher concentration of EPSP. One unit (U) of enzyme activity for all enzymes cited in this work is defined as the amount of enzyme that catalyzes the conversion of 1 mumol of substrate per minute at 25degreesC in an optical path of 1 cm.
###end p 56
###begin title 57
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 0 4 <span type="species:ncbi:1773">MtCS</span>
MtCS enzymatic assay for CS activity
###end title 57
###begin p 58
###xml 4 6 4 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 119 121 118 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 269 271 262 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 366 368 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 471 473 464 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 571 572 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 573 576 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 578 580 565 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 4 8 <span type="species:ncbi:1773">MtCS</span>
###xml 269 273 <span type="species:ncbi:1773">MtCS</span>
###xml 471 475 <span type="species:ncbi:1773">MtCS</span>
The MtCS assay was performed in the forward direction using 15 muL of ESPS-containing solution (see above), 0.04 mM FMNox, 0.3 mM NADH, 0.2 mM MESG, 1 U PNP in buffer A. The reaction mixture was incubated for 4 min at 25degreesC for total consumption of Pi by PNP, and MtCS was then added. The CS reaction was monitored using a coupled reaction with the PNP enzyme [50]. This enzyme catalyses the cleavage of MESG by the inorganic phosphate molecule which is released by MtCS, and formation of 2-amine-6-mercapto-7-methylpurine is monitored at 360 nm (epsilon = 11.0 x 103M-1 cm-1). The assay was performed at 25degreesC and monitored using a Shimadzu UV-2550 spectrophotometer. All measurements, including the blanks, were carried out in triplicate to ensure that reliable data were being collected.
###end p 58
###begin title 59
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 12 15 12 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 0 4 <span type="species:ncbi:1773">MtCS</span>
MtCS and FMNox interaction
###end title 59
###begin p 60
###xml 44 47 44 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 51 53 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 101 104 101 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 385 388 379 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 392 394 386 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 51 55 <span type="species:ncbi:1773">MtCS</span>
###xml 81 85 <span type="species:ncbi:1773">MtCS</span>
###xml 392 396 <span type="species:ncbi:1773">MtCS</span>
The stability of the interaction between FMNox and MtCS was tested by incubating MtCS with excess FMNox in buffer A for 12 hours at 4degreesC in the dark. The mixture was injected into a HiTrapQ HP anion exchange column previously equilibrated with buffer A. The sample was eluted with a linear gradient from 0.0 to 1 M NaCl. Absorption spectrum of the pool of fractions containing FMNox and MtCS was measured at wavelengths values ranging from 210 to 600 nm by a Shimadzu UV-2550 spectrophotometer.
###end p 60
###begin title 61
###xml 3 6 3 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 26 28 26 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 26 30 <span type="species:ncbi:1773">MtCS</span>
FMNox and NADH binding to MtCS measured by, respectively, spectrophotometry and spectrofluorimetry
###end title 61
###begin p 62
###xml 18 21 18 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 24 26 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 83 85 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 676 678 667 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 707 710 698 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 818 821 809 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 24 28 <span type="species:ncbi:1773">MtCS</span>
The binding of FMNox to MtCS (35 muM) was assessed as described by Kitzing et al. [21]. UV-visible difference absorbance spectra were monitored at 25degreesC in a double beam spectrophotometer UV-2550 (Shimadzu) with photometric accuracy of +/- 0.002 absorbance units in the range 0 - 0.5 absorbance. The difference spectra were recorded using quartz cells with two chambers (Hellma GmbH & Co) placing identical arrangements in both the sample (sample cuvette) and reference beam (reference cuvette). Spectra were recorded from 300 to 600 nm. Differences between solutions were minimized by filling both sides (sample and reference cuvettes) from single stock solutions of FMNox. Microliter additions of FMNox to both one chamber of the reference cuvette and to the sample cuvette, followed by mixing of enzyme and FMNox solutions for the latter, allowed direct measurements of the difference spectra. This procedure is almost mandatory when change in absorbance signal is relatively small on interaction. All solutions were in 50 mM Tris-HCl, pH 7.8 (buffer A).
###end p 62
###begin p 63
###xml 195 197 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 746 748 739 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 866 868 859 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 918 922 906 910 <sub xmlns:xlink="http://www.w3.org/1999/xlink">exc </sub>
###xml 946 949 927 930 <sub xmlns:xlink="http://www.w3.org/1999/xlink">em </sub>
###xml 1202 1204 1178 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 195 199 <span type="species:ncbi:1773">MtCS</span>
###xml 746 750 <span type="species:ncbi:1773">MtCS</span>
###xml 866 870 <span type="species:ncbi:1773">MtCS</span>
###xml 1202 1206 <span type="species:ncbi:1773">MtCS</span>
Fluorescence titration was performed at equilibrium in a RF-5301PC Spectrofluorophotometer (Shimadzu) at 25degreesC by making microliter additions of NADH stock solution (10 mM) to 2 mL of 1 muM MtCS (active site concentration) in 50 mM Tris-HCl, pH 7.8 (buffer A). Controls were determined, following exactly the same procedure, by microliter additions of buffer A to account for changes in protein fluorescence due to dilution. In order to assess the NADH inner-filter effect in the fluorimeter, two cuvettes were placed in series so that the contents of the first cuvette acted as a filter of the excitation light and the light emitted from the second cuvette detected. To the first cuvette, NADH was added, while the second cuvette contained MtCS. In this manner, NADH inner-filter effects upon the protein fluorescence could be assessed. The binding of NADH to MtCS causes a quench in protein fluorescence (lambdaexc = 290 nm; 310 </= lambdaem </= 510 nm), and fluorescence values at the maximum emission wavelength (345.5 nm) were plotted against increasing NADH concentrations. The data were fitted to a hyperbolic function, yielding a value of 156 (+/- 12) muM for the dissociation constant of MtCS-NADH binary complex formation.
###end p 63
###begin title 64
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 0 4 <span type="species:ncbi:1773">MtCS</span>
MtCS enzymatic assay for NADH:FMN-oxidoreductase activity
###end title 64
###begin p 65
###xml 26 28 26 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 317 319 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 320 323 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 325 327 313 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 444 446 432 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 452 455 440 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox </sub>
###xml 611 613 598 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 652 654 638 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 26 30 <span type="species:ncbi:1773">MtCS</span>
###xml 444 448 <span type="species:ncbi:1773">MtCS</span>
###xml 611 615 <span type="species:ncbi:1773">MtCS</span>
FMN-reductase activity of MtCS was monitored for the forward reaction 25degreesC in buffer A. The activity measurements were based on the decrease of NADH concentration upon FMN reduction. Owing to the high absorption coefficient of FMN at 360 nm, the consumption of NADH was monitored at 380 nm (epsilon = 0.893 x 103 M-1 cm-1). The apparent steady state kinetic parameters Km and Vmax of FMN reductase activity were determined for holoenzyme MtCS-FMNox in the presence of varying concentrations of NADH (10, 25, 50, 75, 100, 200, 300 muM). The reaction was started with the addition of 60 nmol of homogeneous MtCS previously incubated with 40 muM FMNox.
###end p 65
###begin title 66
Kinetic isotope effects and proton inventory
###end title 66
###begin p 67
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 215 221 215 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">260 nm</sub>
###xml 223 230 223 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340 nm </sub>
###xml 346 348 344 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 387 389 384 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 538 539 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 542 543 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 552 553 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 556 557 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 698 699 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 715 716 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 846 847 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 850 851 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 860 861 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 864 865 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 887 888 884 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1106 1107 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1196 1198 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1222 1224 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 346 350 <span type="species:ncbi:1773">MtCS</span>
[4S-2H]NADH was synthesized as described by Ottolina et al. [51]. The substrates, [4S-4-1H]- or [4S-4-2H]-NADH, were purified on a MonoQ column as previously reported [52], and the fractions with absorbance ratios A260 nm/A340 nm </= 2.3 were pooled. Both kinetic isotope effects and proton inventory were determined in buffer A with homogeneous MtCS previously incubated with 40 muM FMNox. Primary deuterium kinetic isotope effects were determined from measurements of initial rates in the presence of varying concentrations of either [4S-4-1H]- or [4S-4-2H]-NADH, and solvent kinetic isotope effects from measurements of initial rates in the presence of varying concentrations of NADH in either H2O or 91 atom % D2O. Multiple isotope effects were determined by measuring initial velocities in the presence of varying concentrations of either [4S-4-1H]- or [4S-4-2H]-NADH in 90 atom % D2O. The pD of buffers used on solvent and multiple isotope effects were measured on a pH meter considering pD = pH + 0.4. Proton inventory was carried out at saturating NADH concentrations at various mole fractions of D2O. All measurements were performed in triplicate. The nomenclature proposed by Northrop [31] and Cook and Cleland [34] was used to express isotope effects.
###end p 67
###begin title 68
Data analysis
###end title 68
###begin p 69
Values for the apparent kinetic parameters and their standard errors were obtained by fitting the data to the appropriate equations using the non-linear regression function of SigmaPlot 2000 (SPSS, Inc.). The initial rate measured at seven different NADH concentrations were fitted to eq. 1.
###end p 69
###begin p 70

###end p 70
###begin p 71
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K </italic>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 112 114 112 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 139 141 139 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K </italic>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V/K </italic>
###xml 200 204 200 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>V/K </italic></sub>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 209 211 209 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 209 211 209 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>V </italic></sub>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K </italic>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 276 278 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
Isotope effect data were fitted to eq 2, which assumes isotope effects on both V/K and V. In equations 1 and 2, V is the maximal velocity, K is the Michaelis constant, A is substrate concentrations, EV/K and EV are the isotope effects minus 1 on V/K and V, respectively, and Fi is the fraction of deuterium label.
###end p 71
###begin p 72

###end p 72
###begin title 73
Abbreviations
###end title 73
###begin p 74
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arabino</italic>
###xml 200 202 200 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 239 242 239 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">red</sub>
###xml 397 412 394 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 470 472 467 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 501 516 498 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 518 520 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mt</italic>
###xml 546 565 543 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis; Mt</italic>
###xml 591 606 588 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 665 667 662 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nc</italic>
###xml 696 713 693 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurospora crassa</italic>
###xml 944 959 941 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 397 412 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 470 474 <span type="species:ncbi:1773">MtCS</span>
###xml 501 516 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 546 561 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 591 606 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 696 713 <span type="species:ncbi:5141">Neurospora crassa</span>
###xml 944 959 <span type="species:ncbi:1773">M. tuberculosis</span>
CS: chorismate synthase; DAHP: 3-deoxy-D-arabino-heptulosonate 7-phosphate; EPSP: 5-enolpyruvylshikimate-3-phosphate; ESI-MS: electrospray ionization-mass spectrometry; FMN: flavin mononucleotide; FMNox: oxidized flavin mononucleotide; FMNred: reduced flavin mononucleotide; FPLC: fast protein liquid chromatography; IPTG: isopropyl beta-D-thiogalactoside; MDR-TB: multi drug-resistant strains of M. tuberculosis; MESG: 2-amino-6-mercapto-7-methylpurine ribonucleoside; MtCS: chorismate synthase from M. tuberculosis; MtEPSPS: EPSP synthase from M. tuberculosis; MtSK: shikimate kinase from M. tuberculosis; NADH: reduced form of nicotinamide adenine dinucleotide; NcCS: chorismate synthase from Neurospora crassa; PCR: Polymerase Chain Reaction; PEP: phosphoenolpyruvate; PNP: purine nucleotide phosphorylase; SDS-PAGE: sodium docecyl sulfate polyacrylamide gel electrophoresis; TB: tuberculosis; XDR-TB: extensively drug-resistant strains of M. tuberculosis.
###end p 74
###begin title 75
Authors' contributions
###end title 75
###begin p 76
FE carried out protein expression and purification, enzyme kinetic studies, and drafted the manuscript. JESN carried out FMN and NADH binding studies. EKS carried out gene cloning. JF assisted in protein expression and participated in manuscript preparation. MSP carried out mass spectrometry analysis and N-terrminal amino acid sequencing. DSS conceived and coordinated this study, and helped draft the manuscript. LAB participated in experimental design, supervision, and helped draft the manuscript. All authors read and approved the final manuscript.
###end p 76
###begin title 77
Acknowledgements
###end title 77
###begin p 78
We are grateful to Rafael G. Silva for his contribution to the analysis of isotope effects. Financial support for this work was provided by Millennium Initiative Program MCT-CNPq, Ministry of Health-Department of Science and Technology and PRONEX/CNPq/FAPERGS (Brazil) to D.S.S. and L.A.B. D.S.S. (CNPq, 304051/1975-06), L.A.B. (CNPq, 520182/99-5), M.S.P. (CNPq, 500079/90-0), and J.F. (CNPq, 301131/2003-1) are research career awardees from the National Council for Scientific and Technological Development of Brazil.
###end p 78
###begin article-title 79
The growing burden of tuberculosis
###end article-title 79
###begin article-title 80
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
###end article-title 80
###begin article-title 81
Global tuberculosis control: surveillance, planning, financing
###end article-title 81
###begin article-title 82
Resistance to antitubercular drugs
###end article-title 82
###begin article-title 83
###xml 106 109 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Guidelines for preventing the transmission of tuberculosis in health care settings, with special focus on HIV-related issues Rep
###end article-title 83
###begin article-title 84
Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework
###end article-title 84
###begin article-title 85
###xml 13 40 13 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 13 39 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide
###end article-title 85
###begin article-title 86
The future challenges facing the development of new antimicrobial drugs
###end article-title 86
###begin article-title 87
The shikimate pathway - a metabolic tree with many branches
###end article-title 87
###begin article-title 88
The shikimate pathway: early steps in the biosynthesis of aromatic compounds
###end article-title 88
###begin article-title 89
Nutrition, growth and metabolism
###end article-title 89
###begin article-title 90
###xml 68 94 68 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 68 94 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis
###end article-title 90
###begin article-title 91
###xml 27 54 27 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 27 53 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
###end article-title 91
###begin article-title 92
Chorismate synthase: pre-steady-state kinetics of phosphate release from 5-enolpyruvylshikimate 3-phosphate
###end article-title 92
###begin article-title 93
Observation of an isotope effect in the chorismate synthase reaction
###end article-title 93
###begin article-title 94
###xml 94 111 94 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 155 172 155 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurospora crassa</italic>
###xml 94 114 <span type="species:ncbi:83333">Escherichia coli K12</span>
###xml 155 172 <span type="species:ncbi:5141">Neurospora crassa</span>
The overexpression, purification and complete amino acid sequence of chorismate synthase from Escherichia coli K12 and its comparison with the enzyme from Neurospora crassa
###end article-title 94
###begin article-title 95
Chorismate Synthase: An attractive target for drug development against orphan diseases
###end article-title 95
###begin article-title 96
###xml 38 64 38 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 38 64 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Structure of chorismate synthase from Mycobacterium tuberculosis
###end article-title 96
###begin article-title 97
Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability
###end article-title 97
###begin article-title 98
###xml 19 46 19 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 19 51 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
DAHP synthase from Mycobacterium tuberculosis H37Rv: cloning, expression, and purification of functional enzyme
###end article-title 98
###begin article-title 99
###xml 88 105 88 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neurospora crassa</italic>
###xml 88 105 <span type="species:ncbi:5141">Neurospora crassa</span>
Spectroscopic and kinetic characterization of the bifunctional chorismate synthase from Neurospora crassa
###end article-title 99
###begin article-title 100
Crystal structure of chorismate synthase: A novel FMN-binding protein fold and functional insights
###end article-title 100
###begin article-title 101
The structure of chorismate synthase reveals a novel flavin binding site fundamental to a unique chemical reaction
###end article-title 101
###begin article-title 102
Mechanism of chorismate synthase
###end article-title 102
###begin article-title 103
###xml 65 80 <span type="species:ncbi:668">Vibrio fischeri</span>
NAD(P)H-flavin oxidoreductase from the bioluminescent bacterium, Vibrio fischeri ATCC is a flavoprotein
###end article-title 103
###begin article-title 104
Binding of the oxidized, reduced, and radical flavin species to chorismate synthase. An investigation by spectrophotometry, fluorimetry, and electron paramagnetic resonance and electron nuclear double resonance spectroscopy
###end article-title 104
###begin article-title 105
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae chorismate synthase has a flavin reductase activity
###end article-title 105
###begin article-title 106
###xml 119 144 119 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rhodococcus erythropolis </italic>
###xml 119 143 <span type="species:ncbi:1833">Rhodococcus erythropolis</span>
Purification, characterization, and overexpression of flavin reductase involved in dibenzothiophene desulfurization by Rhodococcus erythropolis D-1
###end article-title 106
###begin article-title 107
###xml 46 64 46 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis </italic>
###xml 46 63 <span type="species:ncbi:1423">Bacillus subtilis</span>
Purification and characterization of NfrA1, a Bacillus subtilis nitro/flavin reductase capable of interacting with the bacterial luciferase
###end article-title 107
###begin article-title 108
###xml 42 61 <span type="species:ncbi:879">Desulfovibrio gigas</span>
Molecular determinants for FMN-binding in Desulfovibrio gigas flavoredoxin
###end article-title 108
###begin article-title 109
Steady-state analysis of kinetic isotope effects in enzymic reactions
###end article-title 109
###begin article-title 110
The use of isotope effects to elucidate enzyme mechanisms
###end article-title 110
###begin article-title 111
Kinetic and Regulatory Mechanisms of Enzymes from Isotope Effects
###end article-title 111
###begin article-title 112
Mechanistic deductions from isotope effects in multireactant enzyme mechanisms
###end article-title 112
###begin article-title 113
Theoretical Basis and Mechanistic Utility of Solvent Isotope Effects
###end article-title 113
###begin article-title 114
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fabG</italic>
###xml 52 77 52 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 52 76 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Kinetic and chemical mechanisms of the fabG-encoded Streptococcus pneumoniae beta-ketoacyl-ACP reductase
###end article-title 114
###begin article-title 115
Double isotope fractionation: test for concertedness and for transition-state dominance
###end article-title 115
###begin article-title 116
Use of multiple isotope effects to determine enzyme mechanisms and intrinsic isotope effects
###end article-title 116
###begin article-title 117
Mutagenic analysis of an invariant aspartate residue in chorismate synthase supports its role as an active site base
###end article-title 117
###begin article-title 118
Conservation of NADPH utilization by chorismate synthase and its implications for the evolution of the shikimate pathway
###end article-title 118
###begin article-title 119
###xml 48 75 48 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 48 74 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
A structural model for chorismate synthase from Mycobacterium tuberculosis in complex with coenzyme and substrate
###end article-title 119
###begin article-title 120
Medium-scale structural genomics: strategies for protein expression and crystallization
###end article-title 120
###begin article-title 121
Pure but not simple
###end article-title 121
###begin article-title 122
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
###end article-title 122
###begin article-title 123
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
###end article-title 123
###begin article-title 124
###xml 20 25 <span type="species:ncbi:9796">horse</span>
Characterization of horse kidney metallothionein isoforms by electrospray MS and reversed-phase HPLC-electrospray MS
###end article-title 124
###begin article-title 125
###xml 135 161 135 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 135 161 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis
###end article-title 125
###begin article-title 126
###xml 81 107 81 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 81 107 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
One-step purification of 5-enolpyruvylshikimate-3-phosphate synthase enzyme from Mycobacterium tuberculosis
###end article-title 126
###begin article-title 127
A spectrophotometric method to measure enzymatic activity in reactions that generate inorganic pyrophosphate
###end article-title 127
###begin article-title 128
A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems
###end article-title 128
###begin article-title 129
Enzymatic synthesis of [4R-2H]NAD(P)H and [4S-2H]NAD(P)H and determination of the stereospecificity of 7 alpha- and 12 alpha-hydroxysteroid dehydrogenase
###end article-title 129
###begin article-title 130
High-performance ion-exchange separation of oxidized and reduced nicotinamide adenine dinucleotides
###end article-title 130

